Hydrogel Drug Delivery Device as Alternative to Pressurized Gas or Voltage Transdermal Technology
Wisconsin Alumni Research Foundation (University of Wisconsin)
posted on 02/23/2010
The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a drug delivery device that provides a controlled infusion of a medicine to an individual without using pressurized gas or voltage.
Suggested Uses
- Drug delivery
Advantages
- Does not use pressurized gas or voltage
- Maximizes the volume of drug delivered
- Device is simple and inexpensive to manufacture.
- Chemistry of the hydrogel disc may be altered to provide a desired delivery profile, such as bolus injections, constant infusion or delayed onset.
Detailed Description
Transdermal drug delivery patches offer an alternative. These patches, which incorporate a medicine, adhere to the skin. Molecules of the medicine then pass through the skin and into the bloodstream, providing a specific dose of the medicine. However, existing patches only can be used to deliver small molecule drugs, such contraceptives or those used to treat nicotine addiction. Other transdermal technologies use pressurized gas or voltage to move larger molecules across the skin barrier, but these technologies are limited to small volumes of medicine and may alter the drug.
UW-Madison researchers have developed a drug delivery device that provides a controlled infusion of a drug to an individual. The device includes a reservoir that holds the drug. A predetermined stimulus, which may be activated by the individual, causes a hydrogel to exert pressure on the reservoir, dispensing the drug.
File Number: P09034US
This innovation currently is not available for online licensing. Please contact Emily Bauer at Wisconsin Alumni Research Foundation (University of Wisconsin) for more information.
Find more innovations
